Showing 4,221 - 4,240 results of 5,570 for search '"Oncology"', query time: 0.09s Refine Results
  1. 4221
  2. 4222
  3. 4223
  4. 4224
  5. 4225

    Long-Term Results of Reconstruction with Pelvic Allografts after Wide Resection of Pelvic Sarcomas by Mehmet Ayvaz, Senol Bekmez, M. Ugur Mermerkaya, Omur Caglar, Emre Acaroglu, A. Mazhar Tokgozoglu

    Published 2014-01-01
    “…Reconstruction after the resection of a pelvic tumor is a challenging procedure in orthopedic oncology. The main advantage of allograft reconstruction is restoration of the bony architecture of the complex pelvic region. …”
    Get full text
    Article
  6. 4226
  7. 4227
  8. 4228
  9. 4229
  10. 4230

    Pan-Cancer Analysis of the Cuproptosis-Related Gene DLD by Jiahui Lin, Guowei Wang, Sha Cheng, Yanan Hu, Huan Li, Wanjiang Feng, Xiaoming Liu, Canxia Xu

    Published 2023-01-01
    “…The relationship of DLD with immune microenvironment immunomodulators, immune checkpoints, tumor mutational load (TMB), microsatellite instability (MSI), and oncology drug sensitivity was explored by correlation analysis. …”
    Get full text
    Article
  11. 4231
  12. 4232
  13. 4233

    Trans-Vessel Wall Cell Transplantation, Engraftment, and Tumor Access in the VX2 Rabbit Model by Victoria Lövljung, Mathias Waldén, Mikael Sandell, Peter Damberg, Staffan Holmin, Fabian Arnberg Sandor

    Published 2025-01-01
    “…The trans-vessel wall device (TW-device) is a new endovascular tool for precise and safe delivery of various payloads (cells, viral, modified RNA, chemotherapy, growth factors) in oncology and regenerative medicine. The twofold aim of this study was to assess cell engraftment and tumor growth using the TW-device for endovascular transplantation and to evaluate its ability to directly access solid tumors. …”
    Get full text
    Article
  14. 4234
  15. 4235
  16. 4236

    Validation of Customized Cancer Panel for Detecting Somatic Mutations and Copy Number Alterations by Su-Hye Choi, Seung-Hyun Jung, Yeun-Jun Chung

    Published 2017-12-01
    “…When we applied this system for the analysis of Acrometrix Oncology Hotspot Control DNA, which contains more than 500 COSMIC mutations across 53 genes, 99% of the expected mutations were robustly detected. …”
    Get full text
    Article
  17. 4237

    Beyond immortality: Epstein–Barr virus and the intricate dance of programmed cell death in cancer development by Arezoo Esmaeili, Prankur Awasthi, Samira Tabaee

    Published 2024-01-01
    “…A deeper understanding of the molecular underpinnings of EBV's influence on cell death not only enriches the field of viral oncology but also pinpoints targets for drug development. …”
    Get full text
    Article
  18. 4238

    PET in neurotherapeutic discovery and development by Melissa Chassé, Neil Vasdev

    Published 2025-01-01
    “…In this perspective we discuss the use of PET radioligands in central nervous system (CNS) drug discovery and development, with a focus on recent applications in psychiatry (e.g. 5-HT2A, 11β-HSD1), neuro-oncology (e.g. KRASG12C, ATM, ALK2), and neurodegeneration (e.g. amyloid beta plaques, MAPK p38), while exploring the intricacies associated with developing novel radiotracers for CNS targets. …”
    Get full text
    Article
  19. 4239
  20. 4240